Top Cited Articles
Acceptance rate:
31%
Time to first decision:
8 days
Time to first decision with review:
55 days*
Acceptance to publication:
23 days*
Impact factor:
3.6
Citescore:
5.7
Efficacy of postexposure prophylaxis with doxycycline (Doxy-PEP) in reducing sexually transmitted infections: a systematic review and meta-analysis
Prevalence of Mycoplasma genitalium infection among HIV PrEP users: a systematic review and meta-analysis
Digital interventions for STI and HIV partner notification: a scoping review
Chemsex and risk of sexually transmitted infections: a perspective from India
Embedding a novel screening programme for sexually transmitted infections (chlamydia and gonorrhoea) within an ambulatory emergency surgical assessment unit: an observational cohort study
Is scabies an increasing problem in the UK, and how should the UK Health Security Agency and sexual health services respond?
Impact of national commissioning of pre-exposure prophylaxis (PrEP) on equity of access in England: a PrEP-to-need ratio investigation
Assessing the effectiveness of HIV/STI risk communication displays among Melbourne Sexual Health Centre attendees: a cross-sectional, observational and vignette-based study
A case of chronic bacterial prostatitis due to Mycoplasma genitalium
Case of Haemophilus influenzae urethritis in a male patient
Antimicrobial susceptibility profile of Neisseria gonorrhoeae from patients attending a medical laboratory, Institut Pasteur de Madagascar between 2014 and 2020: phenotypical and genomic characterisation in a subset of Neisseria gonorrhoeae isolates
HIV-1 DNA drug resistance testing to guide successful suppression of low-level viraemia: a case report
The new 2023 BASHH sexually transmitted enteric infections guideline
High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial
Sexual and reproductive health in Britain during the first year of the COVID-19 pandemic: cross-sectional population survey (Natsal-COVID-Wave 2) and national surveillance data
Case of apparent mpox reinfection
Modelling the impact of vaccination and sexual behaviour adaptations on mpox cases in the USA during the 2022 outbreak
Self-sampling strategies (with/without digital innovations) in populations at risk of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review and meta-analyses
Timing of HPV vaccination as adjuvant treatment of CIN2+recurrence in women undergoing surgical excision: a meta-analysis and meta-regression
Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence